On the other hand, using naïvely expressing AR cells, a study by Sarkar et al. 33 found that AURKA is involved in proteosomal degradation of AR, thereby suggesting that inhibiting Aurora activity would promote prostate cancer growth by increasing AR levels and signaling. This evidence concerns the gene AR and prostate carcinoma.